Hims & Hers Health Inc (HIMS)
19.42
-0.95
(-4.66%)
USD |
NYSE |
May 31, 16:00
19.48
+0.06
(+0.31%)
Pre-Market: 20:00
Hims & Hers Health Research and Development Expense (Quarterly): 15.32M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.32M |
| December 31, 2023 | 13.40M |
| September 30, 2023 | 12.27M |
| June 30, 2023 | 11.80M |
| March 31, 2023 | 10.75M |
| December 31, 2022 | 8.311M |
| Date | Value |
|---|---|
| September 30, 2022 | 7.977M |
| June 30, 2022 | 6.861M |
| March 31, 2022 | 6.088M |
| December 31, 2021 | 5.572M |
| September 30, 2021 | 6.242M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
5.572M
Minimum
Dec 2021
15.32M
Maximum
Mar 2024
9.509M
Average
8.311M
Median
Dec 2022